Announcement
Thank you for attending THSNA 2026. The virtual meeting is now closed.
Add to Calendar   Thursday, March 19, 2026 2:45 PM Thursday, March 19, 2026 3:45 PM ET Exploring a Subcutaneous Treatment Option in Hemophilia Care with HYMPAVZI (marstacimab-hncq) (Sponsored by Pfizer, Inc.) THSNA aYaMRExkLzQZmPlsLmNx65599
Exploring a Subcutaneous Treatment Option in Hemophilia Care with HYMPAVZI (marstacimab-hncq) (Sponsored by Pfizer, Inc.)
  Thursday, March 19, 2026           2:45 PM - 3:45 PM ET
 


Description

Session will include a presentation on HYMPAVZI (marstacimab-hncq): the mechanism of action, key clinical trial data, administration guidelines, and patient cases followed by an audience Q&A.
Speaker: Dr. Craig Kessler


This Content is Locked.
Log into a registered attendee account that includes registration for this event/session to access this content.